Security key
23284F105
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX)
CUSIP: 23284F105
Q4 2016 13F Holders as of 31 Dec 2016
- Security type / class
- Equity / Common Stock, $0.00001 par value per share ("Common Stock")
- Total 13F shares
- 16,857,707
- Total 13F value
- $185,279,386
- Share change
- +1,376,948
- SEC-reported price per share
- $10.99
- Number of holders
- 68
- Value change
- +$14,954,410
- Number of buys
- 37
- Number of sells
- 18
- Shares outstanding
- 217,079,600
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2016
Institutions
68
Top holders
10
CTMX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2017
Previous quarter: Q3 2016
CytomX Therapeutics, Inc. SEC filings
CytomX Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23284F105
Recent filing periods:
Ownership snapshot
Top reported holders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2016
13F
Lead comparable stake: 2.5%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 2.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
2.5%
Canaan Partners IX LLC
2%
PUTNAM INVESTMENTS LLC
0.63%
DEERFIELD MANAGEMENT COMPANY, L.P.
0.43%
VANGUARD GROUP INC
0.36%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
2.5%
|
$85,350,000
5,443,262 shares
|
— | 30 Sep 2016 |
| Canaan Partners IX LLC |
13F
Company
|
2%
|
$66,552
4,244,381 shares
|
— | 30 Sep 2016 |
| PUTNAM INVESTMENTS LLC |
13F
Company
|
0.63%
|
$21,479,000
1,369,801 shares
|
— | 30 Sep 2016 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
0.43%
|
$14,793,000
943,433 shares
|
— | 30 Sep 2016 |
| VANGUARD GROUP INC |
13F
Company
|
0.36%
|
$12,303,000
784,646 shares
|
— | 30 Sep 2016 |
| Tekla Capital Management LLC |
13F
Company
|
0.35%
|
$11,855,000
756,090 shares
|
— | 30 Sep 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
68
Shares
16,857,707
Rows available
68
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
61
Q4 2016 holders
68
Holder diff
7
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 value | Q4 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend